167 related articles for article (PubMed ID: 2166154)
1. Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor.
Burk CD; Restaino I; Kaplan BS; Meadows AT
J Pediatr; 1990 Aug; 117(2 Pt 1):331-5. PubMed ID: 2166154
[TBL] [Abstract][Full Text] [Related]
2. [Nephropathy in patients treated with ifosfamide].
Kiss K; Nagy K; Hunyadi K; Simkó R
Orv Hetil; 1994 May; 135(19):1023-6. PubMed ID: 8183542
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide, Fanconi's syndrome, and rickets.
Pratt CB; Meyer WH; Jenkins JJ; Avery L; McKay CP; Wyatt RJ; Hancock ML
J Clin Oncol; 1991 Aug; 9(8):1495-9. PubMed ID: 1649270
[TBL] [Abstract][Full Text] [Related]
4. The development of rickets as a complication of chemotherapy for the treatment of Wilms' tumor.
Segal LS; Palumbo RC; Robertson WW
Orthopedics; 1995 Mar; 18(3):261-4. PubMed ID: 7761316
[TBL] [Abstract][Full Text] [Related]
5. [Ifosfamide-induced nephrotoxicity].
Rossi R; Rath B; Ullrich K; Ehrich JH
Monatsschr Kinderheilkd; 1993 Jul; 141(7):594-601. PubMed ID: 8413339
[TBL] [Abstract][Full Text] [Related]
6. Rickets--a complication of ifosfamide chemotherapy for Wilms tumor.
Relf M; Boal DK
Pediatr Radiol; 1992; 22(3):209-10. PubMed ID: 1324461
[TBL] [Abstract][Full Text] [Related]
7. Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child.
Ashraf MS; Skinner R; English MW; Craft AW; Pearson AD
Med Pediatr Oncol; 1997 Jan; 28(1):62-4. PubMed ID: 8950339
[TBL] [Abstract][Full Text] [Related]
8. Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients.
Rossi R; Gödde A; Kleinebrand A; Riepenhausen M; Boos J; Ritter J; Jürgens H
J Clin Oncol; 1994 Jan; 12(1):159-65. PubMed ID: 8270973
[TBL] [Abstract][Full Text] [Related]
9. Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases.
Rossi R; Helmchen U; Schellong G
Eur J Pediatr; 1992 May; 151(5):384-7. PubMed ID: 1396897
[TBL] [Abstract][Full Text] [Related]
10. [Nephrotoxicity of ifosfamide with special reference to Fanconi Syndrome].
Rogowska E; Woźniak W
Med Wieku Rozwoj; 2004; 8(2 Pt 1):289-95. PubMed ID: 15738605
[TBL] [Abstract][Full Text] [Related]
11. Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients.
Rossi R; Pleyer J; Schäfers P; Kuhn N; Kleta R; Deufel T; Jürgens H
Med Pediatr Oncol; 1999 Mar; 32(3):177-82. PubMed ID: 10064184
[TBL] [Abstract][Full Text] [Related]
12. Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis.
Rossi RM; Kist C; Wurster U; Külpmann WR; Ehrich JH
Pediatr Nephrol; 1994 Apr; 8(2):151-6. PubMed ID: 8018491
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum.
Rossi R; Danzebrink S; Hillebrand D; Linnenbürger K; Ullrich K; Jürgens H
Med Pediatr Oncol; 1994; 22(1):27-32. PubMed ID: 8232077
[TBL] [Abstract][Full Text] [Related]
14. Nephrotoxicity associated with ifosfamide.
Smeitink J; Verreussel M; Schröder C; Lippens R
Eur J Pediatr; 1988 Nov; 148(2):164-6. PubMed ID: 3234441
[TBL] [Abstract][Full Text] [Related]
15. Increased renal parenchymal echogenicity in ifosfamide-induced renal Fanconi syndrome.
Hanquinet S; Wouters M; Devalck C; Perlmutter N; Sariban E
Med Pediatr Oncol; 1995 Feb; 24(2):116-8. PubMed ID: 7990759
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report.
Suarez A; McDowell H; Niaudet P; Comoy E; Flamant F
J Clin Oncol; 1991 Dec; 9(12):2177-82. PubMed ID: 1720453
[TBL] [Abstract][Full Text] [Related]
17. Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.
Daw NC; Gregornik D; Rodman J; Marina N; Wu J; Kun LE; Jenkins JJ; McPherson V; Wilimas J; Jones DP
Eur J Cancer; 2009 Jan; 45(1):99-106. PubMed ID: 18996004
[TBL] [Abstract][Full Text] [Related]
18. Partial and complete de Toni-Debré-Fanconi syndrome after ifosfamide chemotherapy of childhood malignancy.
Rossi R; Ehrich JH
Eur J Clin Pharmacol; 1993; 44 Suppl 1():S43-5. PubMed ID: 8486147
[TBL] [Abstract][Full Text] [Related]
19. Reversible hypophosphatemic rickets following ifosfamide treatment.
Van Gool S; Brock P; Wijndaele G; Van de Casseye W; Kruger M; Proesmans W; Casteels-Van Daele M
Med Pediatr Oncol; 1992; 20(3):254-7. PubMed ID: 1574040
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide induced renal rickets.
Lionel AP; Chinnaswamy G; John RR; Mathai S
Indian J Pediatr; 2014 Sep; 81(9):943-5. PubMed ID: 23912821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
